2Teodori E,Dei S,Scapecchi S,et al. The medicinal chemis try of multidrug resistance (MDR) reversing drugs[J]. Farmaco,2002,57(5) :385-415.
3Liem AA,Chamberlain MP,Wolf CR, et al. The role of signal transduction in cancer treatment and drug resist- ance[J]. Eur J Surg Oncol,2002,28(6) :679-684.
4Markovits J, Larsen AK, Segal-Bendirdjian E, et al. Inhi- bition of DNA topoisomerases Ⅰ and Ⅱ and induction of apoptosis by erbstatin and tyrphostin derviatives[J]. Bio chem Pharmacol, 1994,48 : 549-560.
5Marx G,Zhou H, David E, et al. Covalent attachment of ethidium to DNA results in enhanced topoisomerase Ⅱ-me- diated DNA cleavage [J]. Biochemistry, 1997, 36:15884-15891.
6Bernardini S,Bellincampi L,Ballerini S,et al. Role of GST P1-1 in mediating the effect of etoposide on human neuro blastoma cell line Sh-Sy5y[J]. J Cell Biochem, 2002,86 (2) :340-347.
7Goekkurt E, Hoehn S, Wolschke C, et al. Polymorphisms of glutathione S-transferases(GST) and thymidylate syn thase(TS) novel predictors for response and survival in gastric cancer patients[J]. Br J Cancer, 2006, 94:281-286.
8Ichihara T,Wanibuchi H,Taniyama T,et al. Inhibition of liver glut athione S-transferase placental form positive fo ci development in the rat hepatocarcino-genesis by Por- phyra tenera(Asakusa-nori) [J]. Cancer Lett, 1999,141 : 211-218.
9Tanner B, Pilch H, Schaffer U, et al. Expression of C- erbB 2 and topoisomerase Ⅱ alpha in rdlation to che- moresistance in ovarian cancer[J]. Zentralbl Gynakol,2002,124(3):176-183.
10Korkolopoulou P, Angelopoulou M, Siakantari M, et al. Evalution of DNA topoisomerase Ⅱ a expression provides independent prognostic information in non Hodgkin' s lymphomas[J ]. Histopathology, 2001,38 : 45-53.
